Patents by Inventor Susan E. Johnson

Susan E. Johnson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase
    Publication number: 20040014774
    Abstract: This invention relates to the modulation and/or inhibition of cell signaling, cell proliferation, cell inflammatory response, the control of abnormal cell growth and cell reproduction. More specifically, this invention relates to the use of mono- and/or bicyclic aryl or heteroaryl quinazoline compounds in inhibiting cell proliferation, including compounds which are useful protein tyrosine kinase (PTK) inhibitors. The method of treating cell proliferation and/or differentiation or mediator release using said quinazoline compounds and their use in pharmaceutical compositions is described.
    Type: Application
    Filed: July 10, 2003
    Publication date: January 22, 2004
    Inventors: Michael R. Myers, Alfred P. Spada, Martin P. Maguire, Paul E. Persons, Asher Zilberstein, Chin-Yi Jenny Hsu, Susan E. Johnson
  • Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase
    Patent number: 6645969
    Abstract: This invention relates to the modulation and/or inhibition of cell signaling, cell proliferation, cell inflammatory response, the control of abnormal cell growth and cell reproduction. More specifically, this invention relates to the use of mono- and/or bicyclic aryl or heteroaryl quinazoline compounds in inhibiting cell proliferation, including compounds which are useful protein tyrosine kinase (PTK) inhibitors. The method of treating cell proliferation and/or differentiation or mediator release using said quinazoline compounds and their use in pharmaceutical compositions is described.
    Type: Grant
    Filed: May 18, 1995
    Date of Patent: November 11, 2003
    Assignee: Aventis Pharmaceuticals Inc.
    Inventors: Michael R. Myers, Alfred P. Spada, Martin P. Maguire, Paul E. Persons, Asher Zilberstein, Chin-Yi Jenny Hsu, Susan E. Johnson
  • Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase
    Patent number: 5714493
    Abstract: This invention relates to the treatment of intimation in a patient suffering from such disorder. More specifically, the invention relates to mono- and/or bicyclic aryl or heteroaryl quinazoline compounds in the treatment of inflammation.
    Type: Grant
    Filed: June 4, 1996
    Date of Patent: February 3, 1998
    Assignee: Rhone-Poulenc Rorer Pharmaceuticals, Inc.
    Inventors: Michael R. Myers, Alfred P. Spada, Martin P. Maguire, Paul E. Persons, Asher Zilberstein, Chin-Yi Jenny Hsu, Susan E. Johnson
  • Multi-vesselled beverage container
    Patent number: 5398827
    Abstract: A multi-vesselled beverage container including at least two elongated vessels or tubes which are connected in an adjacent relationship relative to each other. Each tube has an open top portion and a closed bottom portion such that each tube can hold a beverage therein. The tubes are connected such that the top portions of the tubes are disposed in generally coplanar relation relative to each other. The cross-sectional configuration of the tubes are specifically sized toward the top portions thereof to define a cumulative width between opposite sides of the tubes to facilitate simultaneous and direct pouring of the beverages from the tubes into a person's mouth whereat the beverages commingle with each other to provide a taste sensation different than that provided by either individual beverage.
    Type: Grant
    Filed: August 20, 1993
    Date of Patent: March 21, 1995
    Assignee: Flair Communications Agency, Inc.
    Inventors: Robert Armstrong, Susan E. Johnson, Maryann Bott
  • Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase
    Patent number: RE37650
    Abstract: This invention relates to the treatment of intimation in a patient suffering from such disorder. More specifically, the invention relates to mono- and/or bicyclic aryl or heteroaryl quinazoline compounds in the treatment of inflammation.
    Type: Grant
    Filed: February 2, 2000
    Date of Patent: April 9, 2002
    Assignee: Aventis Pharmacetical Products, Inc.
    Inventors: Michael R. Myers, Alfred P. Spada, Martin P. Maguire, Paul E. Persons, Asher Zilberstein, Chin-Yi Jenny Hsu, Susan E. Johnson
  • Dual vesselled beverage container
    Patent number: D356232
    Type: Grant
    Filed: August 20, 1993
    Date of Patent: March 14, 1995
    Assignee: Flair Communications Agency, Inc.
    Inventors: Robert Armstrong, Susan E. Johnson, Maryann Bott